• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对西那卡塞治疗耐药的三发性甲状旁腺功能亢进症。

Tertiary hyperparathyroidism resistant to cinacalcet treatment.

作者信息

Okada Manabu, Tominaga Yoshihiro, Izumi Kumiko, Nobata Hironobu, Yamamoto Takayuki, Hiramitsu Takahisa, Tsujita Makoto, Goto Norihiko, Nanmoku Koji, Watarai Toshihiko, Uchida Kazuharu

机构信息

Department of Transplantation and Endocrine Surgery, Nagoya Second Red Cross Hospital, Showa-ku, Nagoya, Japan.

出版信息

Ther Apher Dial. 2011 Jun;15 Suppl 1:33-7. doi: 10.1111/j.1744-9987.2011.00924.x.

DOI:10.1111/j.1744-9987.2011.00924.x
PMID:21595850
Abstract

Cinacalcet hydrochloride (cinacalcet) has been reported to be efficacious for patients with tertiary hyperparathyroidism (THPT). We experienced five patients with THPT requiring parathyroidectomy (PTx) because of resistance to cinacalcet treatment and investigated their clinical characteristics and clinical course. The maximum diameter of the parathyroid gland estimated by ultrasonography before renal transplantation was evaluated. Serum total calcium, phosphorus, intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), and creatinine (Cr) levels were investigated every three months after the administration of cinacalcet and at PTx. After surgery, the Cr levels were followed. In all five patients, at least one parathyroid gland had a largest diameter of more than 1 cm, and the mean diameter was 18.7 mm (range 14.9-24.1 mm). Intact PTH and ALP levels gradually increased after the initiation of cinacalcet and the Cr levels transiently increased after PTx. These findings suggest that the existence of a severely enlarged nodular hyperplastic gland is a main factor involved in resistance to cinacalcet.

摘要

据报道,盐酸西那卡塞(西那卡塞)对三发性甲状旁腺功能亢进症(THPT)患者有效。我们遇到了5例因对西那卡塞治疗耐药而需要进行甲状旁腺切除术(PTx)的THPT患者,并对他们的临床特征和临床病程进行了调查。评估了肾移植前通过超声检查估计的甲状旁腺最大直径。在给予西那卡塞后每三个月以及在PTx时,对血清总钙、磷、完整甲状旁腺激素(iPTH)、碱性磷酸酶(ALP)和肌酐(Cr)水平进行调查。手术后,对Cr水平进行跟踪。在所有5例患者中,至少有一个甲状旁腺的最大直径超过1 cm,平均直径为18.7 mm(范围为14.9 - 24.1 mm)。开始使用西那卡塞后,iPTH和ALP水平逐渐升高,PTx后Cr水平短暂升高。这些发现表明,存在严重肿大的结节性增生性腺是导致对西那卡塞耐药的主要因素。

相似文献

1
Tertiary hyperparathyroidism resistant to cinacalcet treatment.对西那卡塞治疗耐药的三发性甲状旁腺功能亢进症。
Ther Apher Dial. 2011 Jun;15 Suppl 1:33-7. doi: 10.1111/j.1744-9987.2011.00924.x.
2
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.甲状旁腺体积在继发性甲状旁腺功能亢进的血液透析患者使用西那卡塞治疗后的减少。
Nephron Clin Pract. 2010;115(3):c195-202. doi: 10.1159/000313035. Epub 2010 Apr 23.
3
Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.血液透析患者中结节性增生与西那卡塞治疗继发性甲状旁腺功能亢进疗效抵抗的相关性
Ther Apher Dial. 2010 Dec;14(6):577-82. doi: 10.1111/j.1744-9987.2010.00843.x.
4
Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.西那卡塞对甲状旁腺切除术后继发性甲状旁腺功能亢进的复发有效。
Nephrol Dial Transplant. 2007 Jul;22(7):2056-62. doi: 10.1093/ndt/gfm156. Epub 2007 Apr 20.
5
Response of secondary hyperparathyroidism to cinacalcet depends on parathyroid size.继发性甲状旁腺功能亢进对西那卡塞的反应取决于甲状旁腺的大小。
Nephron Clin Pract. 2010;114(3):c187-93. doi: 10.1159/000262301. Epub 2009 Nov 28.
6
Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism.西那卡塞治疗晚期继发性甲状旁腺功能亢进一年后的甲状旁腺超声图像及生化检查结果
Ther Apher Dial. 2010 Apr;14(2):178-85. doi: 10.1111/j.1744-9987.2009.00781.x.
7
Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?西那卡塞能否替代甲状旁腺干预治疗重度继发性甲状旁腺功能亢进?
Ther Apher Dial. 2009 Oct;13 Suppl 1:S20-7. doi: 10.1111/j.1744-9987.2009.00772.x.
8
Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.血液透析患者继发甲状旁腺功能亢进症对盐酸西那卡塞治疗抵抗后的甲状旁腺组织病理学改变
J Clin Pathol. 2011 Sep;64(9):756-60. doi: 10.1136/jclinpath-2011-200100. Epub 2011 May 12.
9
Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.接受帕立骨化醇治疗无效且需要进行甲状旁腺切除术的晚期继发性甲状旁腺功能亢进血液透析患者甲状旁腺的临床特征及增生模式
Ther Apher Dial. 2007 Aug;11(4):266-73. doi: 10.1111/j.1744-9987.2007.00489.x.
10
Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.甲状旁腺增大的数量可能是晚期继发性甲状旁腺功能亢进症西那卡塞反应的预测因子。
Clin Exp Nephrol. 2012 Apr;16(2):292-9. doi: 10.1007/s10157-011-0547-5. Epub 2011 Oct 20.

引用本文的文献

1
The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.CASR A990G 多态性对继发性甲状旁腺功能亢进血液透析患者接受西那卡塞治疗反应的影响。
Sci Rep. 2021 Sep 9;11(1):18006. doi: 10.1038/s41598-021-97587-8.
2
Association Between Resistance to Cinacalcet and Parathyroid Gland Hyperplasia in Kidney Transplant Recipients with Persistent Hypercalcemia.持续性高钙血症的肾移植受者中,西那卡塞耐药与甲状旁腺增生之间的关联
Int J Organ Transplant Med. 2020;11(3):107-114.
3
Recurrent tertiary hyperparathyroidism due to supernumerary parathyroid glands in a patient receiving long-term hemodialysis: a case report.
一名长期接受血液透析患者因甲状旁腺增生导致复发性三发性甲状旁腺功能亢进:病例报告
BMC Endocr Disord. 2019 Jan 28;19(1):16. doi: 10.1186/s12902-019-0346-7.
4
Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.甲状旁腺结节性增生的风险因素在 sHPT 患者中。
PLoS One. 2017 Oct 17;12(10):e0186093. doi: 10.1371/journal.pone.0186093. eCollection 2017.
5
Unplanned 30-Day Readmissions after Parathyroidectomy in Patients with Chronic Kidney Disease: A Nationwide Analysis.慢性肾病患者甲状旁腺切除术后30天内的非计划再入院情况:一项全国性分析。
Otolaryngol Head Neck Surg. 2017 Dec;157(6):955-965. doi: 10.1177/0194599817721154. Epub 2017 Sep 26.
6
Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.继发性甲状旁腺功能亢进患者西那卡塞反应的药物遗传学分析
Drug Des Devel Ther. 2016 Jul 8;10:2211-25. doi: 10.2147/DDDT.S103370. eCollection 2016.
7
Characteristics of Persistent Hyperparathyroidism After Renal Transplantation.肾移植后持续性甲状旁腺功能亢进的特征
World J Surg. 2016 Mar;40(3):600-6. doi: 10.1007/s00268-015-3314-z.
8
Feline hyperparathyroidism: pathophysiology, diagnosis and treatment of primary and secondary disease.猫甲状旁腺功能亢进:原发性和继发性疾病的病理生理学、诊断与治疗
J Feline Med Surg. 2015 May;17(5):427-39. doi: 10.1177/1098612X15581134.
9
Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.慢性肾脏病中骨化三醇、骨化二醇、甲状旁腺激素和成纤维细胞生长因子-23的相互作用
J Vet Emerg Crit Care (San Antonio). 2013 Mar-Apr;23(2):134-62. doi: 10.1111/vec.12036.
10
Bone turnover in hyperparathyroidism.甲状旁腺功能亢进症中的骨转换
Wien Med Wochenschr. 2013 Sep;163(17-18):391-6. doi: 10.1007/s10354-012-0125-9. Epub 2012 Jul 18.